Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTangible Book ValueTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Accumulated Expenses (2022 - 2024)

Historic Accumulated Expenses for NewGenIvf (NIVF) over the last 3 years, with Q4 2024 value amounting to $201455.0.

  • NewGenIvf's Accumulated Expenses rose 3988.47% to $201455.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $201455.0, marking a year-over-year increase of 3988.47%. This contributed to the annual value of $201455.0 for FY2024, which is 3988.47% up from last year.
  • As of Q4 2024, NewGenIvf's Accumulated Expenses stood at $201455.0, which was up 3988.47% from $144015.0 recorded in Q4 2023.
  • Over the past 5 years, NewGenIvf's Accumulated Expenses peaked at $201455.0 during Q4 2024, and registered a low of $117935.0 during Q4 2022.
  • In the last 3 years, NewGenIvf's Accumulated Expenses had a median value of $144015.0 in 2023 and averaged $154468.3.
  • As far as peak fluctuations go, NewGenIvf's Accumulated Expenses skyrocketed by 2211.39% in 2023, and later soared by 3988.47% in 2024.
  • NewGenIvf's Accumulated Expenses (Quarter) stood at $117935.0 in 2022, then increased by 22.11% to $144015.0 in 2023, then surged by 39.88% to $201455.0 in 2024.
  • Its Accumulated Expenses stands at $201455.0 for Q4 2024, versus $144015.0 for Q4 2023 and $117935.0 for Q4 2022.